Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Mongan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biotechniques|September 10, 2008
Assessment of repeated microarray experiments using mixed tissue RNA reference samplesM Ann Mongan, Ann Mongan, Marnie Higgins, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 25, 2019
Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and AcalabrutinibMelissa Hopper, Tarikere Gururaja, Taisei Kinoshita, et al.
Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.
Rheumatology (Oxford, England)|April 25, 2025
Plasma C4d levels correlate with treatment response and renal activity in proliferative lupus nephritisAgneta Zickert, Caroline Grönwall, Anna Juto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2026
An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's DiseaseRajeev Kumar, Pinky Agarwal, Karen Anderson, et al.
Leukemia Research|September 10, 2020
Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Hana Y Hoh, et al.
Plos One|January 5, 2011
A novel statistical algorithm for gene expression analysis helps differentiate pregnane X receptor-dependent and independent mechanisms of toxicityM Ann Mongan, Robert T Dunn, Steven Vonderfecht, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biotechniques|September 10, 2008
Assessment of repeated microarray experiments using mixed tissue RNA reference samplesM Ann Mongan, Ann Mongan, Marnie Higgins, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 25, 2019
Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and AcalabrutinibMelissa Hopper, Tarikere Gururaja, Taisei Kinoshita, et al.
Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.
Rheumatology (Oxford, England)|April 25, 2025
Plasma C4d levels correlate with treatment response and renal activity in proliferative lupus nephritisAgneta Zickert, Caroline Grönwall, Anna Juto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2026
An Open-Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's DiseaseRajeev Kumar, Pinky Agarwal, Karen Anderson, et al.
Leukemia Research|September 10, 2020
Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Hana Y Hoh, et al.
Plos One|January 5, 2011
A novel statistical algorithm for gene expression analysis helps differentiate pregnane X receptor-dependent and independent mechanisms of toxicityM Ann Mongan, Robert T Dunn, Steven Vonderfecht, et al.
Pageof 1